{
  "trial_id": "NCT00342706",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "African American and Latino primiparous pregnant or newly parenting (0-6 weeks)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Age 15-18 years inclusive",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Teens who are 19 years old if they have not graduated from high school",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Non-English speaking",
      "label": "does_not_trigger",
      "evidence": "unknown"
    },
    {
      "criterion": "Any serious medical condition or disability that would interfere with the participant responding adequately to evaluation measures",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "Obvious cognitive impairment that interferes in participating in informed consent",
      "label": "does_not_trigger",
      "evidence": "unknown"
    },
    {
      "criterion": "Incarceration at enrollment or during the study",
      "label": "does_not_trigger",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has history of acne and mild hirsutism, elevated testosterone levels, gradual enlargement of hands and feet, irregular menstrual cycle, nipple discharge, snoring, headache, facial features of acromegaly, prognathism. Laboratory evaluation reveals IGF-1 of 968 ng/mL and random GH of 19.7 ng/mL.",
  "_meta": {
    "topic_id": "20",
    "trial_id": "NCT00342706",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}